- InVivo Therapeutics Announces Posting of Management Presentation Recording from Annual Shareholders Meeting
- InVivo Therapeutics Appoints Christopher McNulty as Vice President, Business Development & Investor Relations
- InVivo Therapeutics to Present at 4th International Neural Regeneration Symposium in China
- InVivo Therapeutics Announces Barrow Neurological Institute As Third Clinical Trial Site for Neuro-Spinal Scaffold
- InVivo Therapeutics Announces New Responsibilities for Senior Management Team Members
Developing Technology For The Treatment of Spinal Cord Injuries
InVivo Therapeutics Corporation is developing and intends to commercialize groundbreaking technologies for the treatment of spinal cord injuries (SCI). InVivo intends to leverage its platform technology to deliver several products to the market.